The influence of remimazolam on the reversal of rocuronium-induced neuromuscular blockade with sugammadex
Not Applicable
Recruiting
- Conditions
- Patients scheduled for elective surgery under general anesthesia
- Registration Number
- JPRN-jRCT1071230073
- Lead Sponsor
- Fujimoto Masafumi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients over 18 years old scheduled for elective surgery under general anesthesia. All patients were American Society of Anesthesiologists physical status class I or II.
Exclusion Criteria
Patients under 18 years old, emergency surgery, obesity (BMI 30 kg/m2 and more), with hepatic and renal dysfunction, with neuromuscular disorder, with contraindication to benzodiazepine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time from sugamadex administration to TOF ratio 0.90 and more
- Secondary Outcome Measures
Name Time Method Time from initial rocuronium administration to TOF count 0, to reappearance of T1 and T2, and total rocuronium dose used during the surgery.